Furthermore, direct delivery of CXCL11 to the tumor site via the oncolytic vaccinia virus was found to be more efficient in inducing cancer cell killing in vivo than the secretion of CXCL11 by CAR-T cells themselves [157]. The gene discussed is CXCL11; the disease is cancer.